Entering text into the input field will update the search result below

Neuroprosthetics Market Development And Business Intelligence

Sep. 21, 2021 3:24 AM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Summary

  • Major factors influencing the growth of the market.
  • Leading players & Business Strategies.
  • Geographic Overview.

Market growth influenced due to following factors-

  • The increasing number of patients suffering from neurological disorders and nerve injury.
  • Growing incidence of hearing loss, increasing cases of amputations due to the rising number of accidents & injuries.

Global market size-

According to research report global neuroprosthetics market is projected to reach USD 10.48 billion by 2022 from USD 5.84 billion in 2017, at a CAGR of 12.4%. 

Leading Players-

Some of the major players operating in the Neuroprosthetics Market are Boston Scientific (US), LivaNova (UK), Medtronic (US), Abbott (US), Cochlear (Australia), and Second sight (US).

For details Download PDF Brochure Here

Geographic Overview -

Based on region, the neuroprosthetics market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2017, North America is expected to command the largest share of the neuroprosthetics market.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.